Zijing Biotech

Zijing Biotech is invested by Zijing Group (Beijing), with a total investment of 36 million yuan. Zijing Biotech (referred to as: Zijing Hui Kang) is a company mainly engaged in pharmaceutical technology, focusing on the research and development, production, and sales of medical devices, biological testing, and disinfection and epidemic prevention products. It has completed the first phase of investment of nearly 26 million yuan, carried out the initial completion of the production environment and workshop GMP, and completed the internal transfer and registration of a product through purchase, cooperation and other forms from related enterprises in other provinces and within the group. It has reached a strategic cooperation with Central South University, becoming a joint graduate student training base of Central South University, and also a key experimental base for the transformation of industry, academia, and research at Central South University.